Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-145' Or cancer = '' Total: 147 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-145 basal cell carcinoma down Expression of microRNAs in basal cell carcinoma.
hsa-mir-145 bladder cancer down miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.
hsa-mir-145 bladder cancer down MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-145 bladder cancer down Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-145 bladder cancer down socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells.
hsa-mir-145 bladder cancer down Aberrant expression of microRNAs in bladder cancer.
hsa-mir-145 bladder cancer down miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.
hsa-mir-145 bladder cancer down Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
hsa-mir-145 bladder cancer down Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145.
hsa-mir-145 breast cancer down miR-145 inhibits breast cancer cell growth through RTKN.
hsa-mir-145 breast cancer down miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
hsa-mir-145 breast cancer down MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.
hsa-mir-145 breast cancer down Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
hsa-mir-145 breast cancer down MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
hsa-mir-145 breast cancer down miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
hsa-mir-145 breast cancer down miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-?1 expression.
hsa-mir-145 breast cancer down Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.
hsa-mir-145 cervical cancer down Glucocorticoid regulation of a novel HPV E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
hsa-mir-145 cervical cancer down Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
hsa-mir-145 cervical cancer down A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
hsa-mir-145 cervical cancer down Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
hsa-mir-145 chondrosarcoma down The Epigenetic Regulation of SOX9 by miR-145 in Human Chondrosarcoma.
hsa-mir-145 colon cancer down Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
hsa-mir-145 colon cancer down MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.
hsa-mir-145 colon cancer down Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-145 colon cancer down Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
hsa-mir-145 colon cancer up miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
hsa-mir-145 colon cancer down Inhibition of SW620 human colon cancer cells by upregulating miRNA-145.
hsa-mir-145 colon cancer down miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
hsa-mir-145 colon cancer down Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
hsa-mir-145 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-145 colorectal cancer down MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-145 colorectal cancer down Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.
hsa-mir-145 colorectal cancer down RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
hsa-mir-145 colorectal cancer down MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.
hsa-mir-145 colorectal cancer up Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer.
hsa-mir-145 colorectal cancer down Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
hsa-mir-145 colorectal cancer down MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.
hsa-mir-145 colorectal cancer down Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.
hsa-mir-145 colorectal cancer down miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
hsa-mir-145 colorectal cancer down MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.
hsa-mir-145 colorectal cancer down microRNA-145 regulates tumor suppressor candidate 3 and mitogen-activated protein kinase pathway to inhibit the progression of colorectal cancer.
hsa-mir-145 colorectal carcinoma down Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-145 endometrial cancer up Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
hsa-mir-145 endometrial cancer down Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
hsa-mir-145 esophageal cancer down Episomal lentiviral vector-mediated miR-145 overexpression inhibits proliferation and induces apoptosis of human esophageal carcinoma cells.
hsa-mir-145 esophageal cancer down miR-145 targets the SOX11 3'UTR to suppress endometrial cancer growth.
hsa-mir-145 esophageal cancer up MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5.
hsa-mir-145 esophageal squamous cell carcinoma down miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-145 esophageal squamous cell carcinoma up Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
hsa-mir-145 esophageal squamous cell carcinoma down MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-145 esophageal squamous cell carcinoma down miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.
hsa-mir-145 esophageal squamous cell carcinoma down Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma.
hsa-mir-145 esophageal squamous cell carcinoma down MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
hsa-mir-145 gallbladder carcinoma up miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
hsa-mir-145 gastric cancer down MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-145 gastric cancer down [Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].
hsa-mir-145 gastric cancer down MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer.
hsa-mir-145 gastric cancer down miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.
hsa-mir-145 glioblastoma down NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145 glioblastoma down Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
hsa-mir-145 glioblastoma down MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.
hsa-mir-145 glioblastoma down miR-145 is a potential biomarker for predicting clinical outcome in glioblastomas.
hsa-mir-145 glioma down NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145 glioma down MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
hsa-mir-145 glioma down ROCK1, a novel target of miR-145, promotes glioma cell invasion.
hsa-mir-145 glioma down miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2.
hsa-mir-145 glioma down miR-145 is a potential biomarker for predicting clinical outcome in glioblastomas.
hsa-mir-145 hepatocellular carcinoma down Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-145 hepatocellular carcinoma down MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
hsa-mir-145 hepatocellular carcinoma down miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17.
hsa-mir-145 hepatocellular carcinoma down MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).
hsa-mir-145 hepatocellular carcinoma down MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
hsa-mir-145 hepatocellular carcinoma down MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.
hsa-mir-145 hepatocellular carcinoma down MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
hsa-mir-145 hepatocellular carcinoma down MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
hsa-mir-145 hepatocellular carcinoma down Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.
hsa-mir-145 hepatocellular carcinoma down Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma.
hsa-mir-145 intrahepatic cholangiocarcinoma down MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
hsa-mir-145 kidney cancer down MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients.
hsa-mir-145 laryngeal squamous cell carcinoma down MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma.
hsa-mir-145 laryngeal squamous cell carcinoma down Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.
hsa-mir-145 laryngeal squamous cell carcinoma down Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145.
hsa-mir-145 liver cancer down MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.
hsa-mir-145 lung adenocarcinoma down Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
hsa-mir-145 lung adenocarcinoma down MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.
hsa-mir-145 lung adenocarcinoma down microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
hsa-mir-145 lung adenocarcinoma down [miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].
hsa-mir-145 lung adenocarcinoma down MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.
hsa-mir-145 lung adenocarcinoma down MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.
hsa-mir-145 lung cancer down Uncovering growth-suppressive MicroRNAs in lung cancer.
hsa-mir-145 lung cancer down MicroRNA-145 inhibits lung cancer cell metastasis.
hsa-mir-145 lung cancer down MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer.
hsa-mir-145 lung cancer up Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.
hsa-mir-145 lung cancer down Interaction of lincRNA ROR and p53/miR-145 correlates with lung cancer stem cell signatures.
hsa-mir-145 nasopharyngeal carcinoma down MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-145 nasopharyngeal carcinoma down miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
hsa-mir-145 nasopharyngeal carcinoma down MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.
hsa-mir-145 neuroblastoma down NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
hsa-mir-145 non-small cell lung cancer down miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
hsa-mir-145 non-small cell lung cancer down Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.
hsa-mir-145 non-small cell lung cancer down MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer.
hsa-mir-145 non-small cell lung cancer down Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.
hsa-mir-145 non-small cell lung cancer up Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
hsa-mir-145 non-small cell lung cancer down Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.
hsa-mir-145 non-small cell lung cancer down MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
hsa-mir-145 non-small cell lung cancer down MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
hsa-mir-145 non-small cell lung cancer down miR-145 and miR-497 suppress TGF-?-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.
hsa-mir-145 non-small cell lung cancer down Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer.
hsa-mir-145 oral squamous cell carcinoma down Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.
hsa-mir-145 oral squamous cell carcinoma down MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.
hsa-mir-145 oral squamous cell carcinoma down Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
hsa-mir-145 osteosarcoma down MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells.
hsa-mir-145 osteosarcoma down microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.
hsa-mir-145 osteosarcoma down miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.
hsa-mir-145 osteosarcoma down MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16.
hsa-mir-145 osteosarcoma up miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
hsa-mir-145 osteosarcoma down MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
hsa-mir-145 ovarian cancer down MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer.
hsa-mir-145 ovarian cancer down MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
hsa-mir-145 ovarian cancer down Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-145 ovarian cancer down miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.
hsa-mir-145 ovarian cancer down miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
hsa-mir-145 ovarian cancer down Quercetin induces the apoptosis of human ovarian carcinoma cells by upregulating the expression of microRNA-145.
hsa-mir-145 pancreatic adenocarcinoma down MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.
hsa-mir-145 pancreatic cancer down MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.
hsa-mir-145 pancreatic cancer down MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells.
hsa-mir-145 pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-145 primary cns lymphomas down Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-145 prostate cancer down The functional significance of microRNA-145 in prostate cancer.
hsa-mir-145 prostate cancer down Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
hsa-mir-145 prostate cancer down MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
hsa-mir-145 prostate cancer down The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
hsa-mir-145 prostate cancer down miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
hsa-mir-145 renal cell carcinoma down The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
hsa-mir-145 renal cell carcinoma down miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
hsa-mir-145 retinoblastoma down miR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
hsa-mir-145 uveal melanoma down MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
hsa-mir-145-3p non-small cell lung cancer down microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
hsa-mir-145-5p colorectal cancer down Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
hsa-mir-145-5p esophageal squamous cell carcinoma down miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-?B Signaling Pathway in Esophageal Squamous Cell Carcinoma.
hsa-mir-145-5p gastric cancer down MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition.
hsa-mir-145-5p gastric cancer down Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
hsa-mir-145-5p gastric cancer down Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.
hsa-mir-145-5p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-145-5p laryngeal squamous cell carcinoma down Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
hsa-mir-145-5p non-small cell lung cancer down miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells.